These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38847215)

  • 1. Model-based bioequivalence approach for sparse pharmacokinetic bioequivalence studies: Model selection or model averaging?
    Philipp M; Tessier A; Donnelly M; Fang L; Feng K; Zhao L; Grosser S; Sun G; Sun W; Mentré F; Bertrand J
    Stat Med; 2024 Aug; 43(18):3403-3416. PubMed ID: 38847215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of model misspecification on model-based tests in PK studies with parallel design: real case and simulation studies.
    Guhl M; Mercier F; Hofmann C; Sharan S; Donnelly M; Feng K; Sun W; Sun G; Grosser S; Zhao L; Fang L; Mentré F; Comets E; Bertrand J
    J Pharmacokinet Pharmacodyn; 2022 Oct; 49(5):557-577. PubMed ID: 36112338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Model-Based Bioequivalence Statistical Approaches for Pharmacokinetic Studies with Sparse Sampling.
    Loingeville F; Bertrand J; Nguyen TT; Sharan S; Feng K; Sun W; Han J; Grosser S; Zhao L; Fang L; Möllenhoff K; Dette H; Mentré F
    AAPS J; 2020 Oct; 22(6):141. PubMed ID: 33125589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of model-based bioequivalence approach for single sample pharmacokinetic studies.
    Tardivon C; Loingeville F; Donnelly M; Feng K; Sun W; Sun G; Grosser S; Zhao L; Fang L; Mentré F; Bertrand J
    CPT Pharmacometrics Syst Pharmacol; 2023 Jul; 12(7):904-915. PubMed ID: 37114321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient model-based bioequivalence testing.
    Möllenhoff K; Loingeville F; Bertrand J; Nguyen TT; Sharan S; Zhao L; Fang L; Sun G; Grosser S; Mentré F; Dette H
    Biostatistics; 2022 Jan; 23(1):314-327. PubMed ID: 32696053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inference of bioequivalence for log-normal distributed data with unspecified variances.
    Xu S; Hua SY; Menton R; Barker K; Menon S; D'Agostino RB
    Stat Med; 2014 Jul; 33(17):2924-38. PubMed ID: 24403216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model-based analyses of bioequivalence crossover trials using the stochastic approximation expectation maximisation algorithm.
    Dubois A; Lavielle M; Gsteiger S; Pigeolet E; Mentré F
    Stat Med; 2011 Sep; 30(21):2582-600. PubMed ID: 21793036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New approach to assess bioequivalence parameters using generalized gamma mixed-effect model (model-based asymptotic bioequivalence test).
    Chen YI; Huang CS
    Stat Med; 2014 Feb; 33(5):786-97. PubMed ID: 24105871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlling the type I error rate in two-stage sequential adaptive designs when testing for average bioequivalence.
    Maurer W; Jones B; Chen Y
    Stat Med; 2018 May; 37(10):1587-1607. PubMed ID: 29462835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of model-integrated evidence approaches for pharmacokinetic bioequivalence studies using model averaging methods.
    Bjugård Nyberg H; Chen X; Donnelly M; Fang L; Zhao L; Karlsson MO; Hooker AC
    CPT Pharmacometrics Syst Pharmacol; 2024 Oct; 13(10):1748-1761. PubMed ID: 39205490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing a Bayesian Approach (BEST) with the Two One-Sided t-Tests (TOSTs) for Bioequivalence Studies.
    Peck C; Campbell G; Yoo I; Feng K; Hu M; Zhao L
    AAPS J; 2022 Sep; 24(5):97. PubMed ID: 36050426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An approximate approach to sample size determination in bioequivalence testing with multiple pharmacokinetic responses.
    Tsai CA; Huang CY; Liu JP
    Stat Med; 2014 Aug; 33(19):3300-17. PubMed ID: 24771655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of Multiple-Batch Approaches to Pharmacokinetic Bioequivalence Testing for Orally Inhaled Drug Products with Batch-to-Batch Variability.
    Burmeister Getz E; Carroll KJ; Christopher JD; Morgan B; Haughie S; Cavecchi A; Wiggenhorn C; Beresford H; Strickland H; Lyapustina S
    AAPS PharmSciTech; 2021 Aug; 22(7):225. PubMed ID: 34410557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advantage of population pharmacokinetic method for evaluating the bioequivalence and accuracy of parameter estimation of pidotimod.
    Huang J; Li M; Lv Y; Yang J; Xu L; Wang J; Chen J; Wang K; He Y; Zheng Q
    Int J Clin Pharmacol Ther; 2016 Sep; 54(9):682-92. PubMed ID: 27390049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of non-compartmental and mixed effect modelling methods for establishing bioequivalence for the case of two compartment kinetics and censored concentrations.
    Hughes JH; Upton RN; Foster DJR
    J Pharmacokinet Pharmacodyn; 2017 Jun; 44(3):233-244. PubMed ID: 28194623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple testing for bioequivalence with pharmacokinetic data in 2 x 2 crossover designs.
    Chen YI; Huang CS
    Stat Med; 2009 Dec; 28(28):3567-79. PubMed ID: 19760611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioequivalence tests based on individual estimates using non-compartmental or model-based analyses: evaluation of estimates of sample means and type I error for different designs.
    Dubois A; Gsteiger S; Pigeolet E; Mentré F
    Pharm Res; 2010 Jan; 27(1):92-104. PubMed ID: 19876723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Batch Selection via In Vitro/In Vivo Correlation in Pharmacokinetic Bioequivalence Testing.
    Burmeister Getz E; Carroll KJ; Mielke J; Jones B; Benet LZ
    AAPS PharmSciTech; 2021 Aug; 22(7):224. PubMed ID: 34410534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equivalence assessment for interchangeability based on two-sided tests.
    Dong X; Tsong Y
    J Biopharm Stat; 2014; 24(6):1312-31. PubMed ID: 25032976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Bioequivalence Established Based on the Reference-Scaled Average Bioequivalence Approach Relevant to Chronic Administration of Phenytoin? Perspectives Based on Population Pharmacokinetic Modeling and Simulations.
    Kim H; Fang L; Yu J; Meng Z; Trame MN; Schmidt S; Lesko LJ; Zhao L
    J Clin Pharmacol; 2019 Aug; 59(8):1061-1069. PubMed ID: 30716169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.